You can buy or sell STSA and other stocks, options, ETFs, and crypto commission-free!
Satsuma Pharmaceuticals, Inc. Common Stock, also called Satsuma Pharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It develops novel therapeutic products for the acute treatment of migraine. The company was founded by John Kollins on June 21, 2016 and is headquartered in San Francisco, CA.
San Francisco, California
52 Week High
52 Week Low
Expected Mar 12, After Hours